FDA Warns Lancome For Gene/Stem-Cell Claims: A Signal To Marketplace?
This article was originally published in The Tan Sheet
Executive Summary
Claims for L’Oreal’s Lancome brand’s Genifique anti-aging line identify the products as drugs, FDA says. The agency cites claims that the brand’s technology “boosts the activity of genes” and “has been shown to improve the condition” around stem cells – language not unique in the anti-aging cosmeceutical market.